JADPRO Live 2018 Activities
JADPRO Live 2017 Activities
Relapsed/Refractory Multiple Myeloma
Management of irAEs
Managing Classical Hodgkin Lymphoma
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
Learn more on this topic:
Nuances in the Management of Aggressive Lymphomas
How does genetic information affect treatment decisions in aggressive lymphoma, such as DLBCL?
Paul Hamlin, MD
Memorial Sloan Kettering Cancer Center
What are the unique side effects associated with venetoclax?
What is the role of immunotherapy in aggressive lymphoma? What do APs need to know about managing immune-related adverse events in patients?
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.